Document is current

Article History

Received: 10 July 2024

Accepted: 2 October 2024

First Online: 19 October 2024

Declarations

:

: Dr. Segar reports speaker fees from Merck & Co and grant support from the American Heart Association outside the present study. Dr. Subramanian is supported by the National Institutes of Health Grant for Stimulating access to Research in Residency (UT-STaRR) program (R38HL150214). Dr. Keshvani has received consultant fees from Heart Test Laboratories and Tricog Health. He is supported by the National Heart, Lung, and Blood Institute T32 postdoctoral training grant (5T32HL125247-09). Dr. Pandey has received grant funding outside the present study from Applied Therapeutics and Gilead Sciences; has received honoraria outside the present study as an advisor/consultant for Tricog Health Inc. and Lilly, USA, Rivus, Roche Diagnostics, Axon Therapies, Semler Scientific, Medtronic, Edwards Lifesciences, Science37, Novo Nordisk, Bayer, Merck, Sarfez Pharmaceuticals, Emmi Solutions, Palomarin Inc; and has received nonfinancial support from Pfizer and Merck. He has received research support from the National Institute on Aging GEMSSTAR Grant (1R03AG067960-01) and the National Institute on Minority Health and Disparities (R01MD017529). The other authors have no relevant disclosures.